Proteomics International will be showcasing PromarkerD at the 58th ERA-EDTA Congress, Europe’s leading conference for kidney health from 5th–8th of June 2021. Intended to be a hybrid conference based both virtually and in Berlin, due to the global pandemic the Congress is now fully virtual. Approximately 5,000 nephrologists, transplantation experts and global healthcare leaders meet each year at the ERA-EDTA Congress to network and learn about the latest advances in kidney health treatment and technology.
PromarkerD can predict Diabetic Kidney Disease (DKD) up to 4 years before symptoms present. A simple test measures 3 plasma biomarkers and 3 clinical factors.